• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Asia Pacific Insomnia Market Trends

    ID: MRFR/Pharma/0176-HCR
    50 Pages
    Kinjoll Dey
    October 2025

    Asia Pacific Insomnia Market Research Report, By Types Of Therapy (Pharmacological Therapy And Non-Pharmacological Therapy), By Drug Formulation (Capsules, Tablet And Others), By Type Of Diseases (Poor Quality Of Sleep, Sleep Maintenance And Other) - Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Asia Pacific Insomnia Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Trends

    Key Emerging Trends in the Asia Pacific Insomnia Market

    The Asia Pacific insomnia market is seeing enormous patterns molded by fast urbanization and way of life changes. As populations in key urban communities develop, the predominance of insomnia is on the rise, driven by elements, for example, business related pressure, expanded screen time, and changing sleep patterns. One of the remarkable patterns is the rising maturing populace across Asia Pacific. With age, the probability of encountering sleep issues, including insomnia, rises. This segment shift is driving the interest for insomnia arrangements, making a remarkable market dynamic. The drug area overwhelms the insomnia market in Asia Pacific, with a striking extension in the turn of events and distribution of sleep medications. Both solution and non-prescription medications are seeing expanded request as people look for successful solutions for address their sleep lacks. Asia Pacific stands apart for its rich legacy of conventional medication. An arising pattern is the combination of conventional cures, for example, natural details and Ayurvedic practices, into insomnia management. Purchasers are showing interest in all-encompassing approaches that line up with social inclinations. The Asia Pacific insomnia market is embracing telemedicine and online counsels as practical options for getting to sleep-related healthcare managements. The accommodation of virtual interviews with sleep trained professionals and the availability of computerized mediations add to the market's advancement. Social variety across the Asia Pacific area impacts sleep practices and impression of insomnia. Market players are adjusting their procedures to address these social subtleties, perceiving the significance of tailoring mediations to resound with the assorted convictions and ways of life of the population. A pattern towards expanded customer training is obvious as people become more proactive in looking for data about sleep health. This pattern is driving an interest for instructive assets, studios, and awareness campaigns focused in on advancing healthy sleep tendencies and tending to insomnia. There is an outstanding movement towards non-pharmacological mediations for overseeing insomnia in Asia Pacific. Mental social treatment for insomnia (CBT-I), unwinding methods, and way of life adjustments are gaining visibleness as people look for without drug choices for long term help.

    Market Summary

    As per Market Research Future Analysis, the Asia Pacific Insomnia Market was valued at USD 0.14 Billion in 2023 and is projected to grow to USD 0.20 Billion by 2032, with a CAGR of 8.12% from 2024 to 2032. Insomnia, the most prevalent sleep disorder, affects a significant portion of the population, particularly women and younger individuals. Factors such as increased alcohol, caffeine, and tobacco consumption, along with psychological and behavioral issues, are driving the rise in insomnia cases. The market is further supported by technological advancements and rising healthcare expenditures. However, a lack of education and awareness may hinder growth.

    Key Market Trends & Highlights

    The Asia Pacific Insomnia Market is witnessing significant growth driven by various factors.

    • Market Size in 2023: USD 0.14 Billion
    • Projected Market Size by 2032: USD 0.20 Billion
    • CAGR from 2024 to 2032: 8.12%
    • Japan holds the largest market share, with 1 in 5 people affected by insomnia.

    Market Size & Forecast

    2023 Market Size USD 0.14 Billion
    2024 Market Size USD 0.18 Billion
    2032 Market Size USD 0.20 Billion
    CAGR 8.12%.

    Major Players

    Key players include Takeda Pharmaceutical Company, Pfizer, Inc., Eisai, Co., Merck & Co Inc, Sanofi, and GlaxoSmithKline Plc.

    Market Trends

    Asia Pacific Insomnia Market Market Drivers

    Market Segment Insights

    Regional Insights

    Key Companies in the Asia Pacific Insomnia Market market include

    Industry Developments

    Market Segmentation

    Asia Pacific Insomnia Market Segmentation

    Asia Pacific Insomnia Market Intended Audience
    • Manufacturing and packaging industries
    • Insomnia devices and drug manufacturers
    • Insomnia devices and drug suppliers
    • Biotechnology Companies
    • Bio-Pharmaceutical Companies
    • Research and Development (R&D) Companies
    • Government Research Laboratories
    • {" "=>[]}

    Report Scope

    Attribute/Metric Details
    Market Size USD 0.20 Billion by 2032
    CAGR 8.12% (2024-2032)
    Base Year   2023
    Forecast Period   2024-2032
    Historical Data   2021
    Forecast Units   Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Types, end user, Region
    Geographies Covered Asia Pacific
    Key Vendors Takeda Pharmaceutical Company (Japan), Pfizer, Inc. (US), Eisai, Co. (Japan),  Merck & Co Inc (US), Sanofi (France),  GlaxoSmithKline Plc. (UK), Meda Consumer Healthcare Inc (US), Care Fusion Corporation (US), Pernix Therapeutics (US), Purdue Pharma L.P. (US), Consumer Healthcare Inc. (Canada), Dainippon Sumitomo (Japan), ECR Pharmaceuticals (US), Johnson & Johnson (US),  Astellas (UK), Biocodex S A (France), Neurim (Switzerland), Flynn Pharma (UK)

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    1. Table of Contents 1    INTRODUCTION    
      1.     DEFINITION    
      2.     SCOPE OF STUDY    
        1.     RESEARCH OBJECTIVE    
        2.     ASSUMPTIONS & LIMITATIONS    
      3.     MARKET STRUCTURE:    
    2. 2    Research Methodology    
      1.     RESEARCH PROCESS:    
      2.     PRIMARY RESEARCH    
      3.     SECONDARY RESEARCH:    
    3. 3    MARKET DYNAMICS    
      1.     DRIVERS    
      2.     RESTRAINTS        
      3.     OPPORTUNITIES    
      4.     MACROECONOMIC INDICATORS    
    4. 4    MARKET FACTOR ANALYSIS    
      1.     PORTERS FIVE FORCES MODEL    
      2.     BARGAINING POWER OF SUPPLIERS    
      3.     BARGAINING POWER OF BUYERS    
      4.     THREAT OF NEW ENTRANTS    
      5.     THREAT OF SUBSTITUTES    
      6.     INTENSITY OF RIVALRY    
    5.     ASIA PACIFIC INSOMNIA MARKET, BY TYPES OF THERAPY 
      1.     PHARMACOLOGICAL THERAPY 
        1.     BENZODIAZEPINES
        2.     NON-BENZODIAZEPINES
        3.     MELATONIN RECEPTOR AGONISTS 
        4.     OTHER
      2.     NON PHARMACOLOGICAL THERAPY 
        1.     RELAXATION THERAPY
        2.     COGNITIVE BEHAVIORAL THERAPY
        3.     SLEEP HYGIENE EDUCATION
        4.     STIMULUS CONTRO
        5.     PARADOXICAL INTENTION 
        6.     OTHER
    6.     ASIA PACIFIC INSOMNIA MARKET, BY DRUG FORMULATION 
      1.     CAPSULES
      2.     TABLET 
      3.     OTHERS.
    7.     ASIA PACIFIC INSOMNIA MARKET, BY TYPE OF DISEASE
      1.     POOR QUALITY OF SLEEP
      2.     SLEEP MAINTENANCE 
      3.     OTHER.
    8.     GLOBAL INSOMNIA MARKET, BY REGION
      1.     INTRODUCTION
        1.     JAPAN
        2.     CHINA
        3.     INDIA
        4.     AUSTRALIA
        5.     REPUBLIC OF KOREA
        6.     REST OF ASIA-PACIFIC
    9.     Competitive Landscape    
      1.     MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS    
        1.     STRATEGIC PARTNERSHIP    
        2.     MERGER & ACQUISITION    
    10. 10    COMPANY PROFILE    
      1.     EISAI, CO.
        1.     OVERVIEW    
        2.     PRODUCT OVERVIEW    
        3.     FINANCIALS    
        4.     KEY DEVELOPMENTS    
      2.     MERCK & CO INC
        1.     OVERVIEW    
        2.     PRODUCT OVERVIEW    
        3.     FINANCIALS    
        4.     KEY DEVELOPMENTS    
      3.     TAKEDA PHARMACEUTICAL COMPANY
        1.     OVERVIEW
        2.     PRODUCT OVERVIEW    
        3.     FINANCIALS
        4.     STRATEGY    
        5.     KEY DEVELOPMENT    
      4.     SANOFI
        1.     OVERVIEW
        2.     PRODUCT OVERVIEW
        3.     FINANCIALS
        4.     KEY DEVELOPMENTS    
      5.     PFIZER, INC.
        1.     OVERVIEW
        2.     PRODUCT OVERVIEW    
        3.     FINANCIALS    
        4.     KEY DEVELOPMENTS    
      6.     OTHERS
    11.          CONCLUSION
    12. 12       Key Findings
      1.     FROM CEO’S VIEWPOINT 
        1.     UNMET NEEDS OF THE MARKET 
      2.       KEY COMPANIES TO WATCH
      3.       PREDICTION OF INSOMNIA CARE INDUSTRY
    13.     APPENDIX
    14.  

    Insomnia Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials